| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $122.25 | $24.61 | 396.73% | 230.66x | 209.55x | 15.51x | 18.72x | 1.79x | $106.92M | 0.83% | $705.78M | 6.70 | $13.11B | 1,671.56 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $236.22 | $94.88 | 148.96% | 38.72x | 32.61x | 6.57x | 23.34x | 1.18x | $793.95M | 2.52% | $1.35B | 10.14 | $32.89B | 27.89 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $79.03 | $16.47 | 379.81% | 73.86x | 62.77x | 7.29x | 9.43x | 2.29x | $182.84M | 2.98% | $654.15M | 8.43 | $6.00B | 50.01 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $25.08 | $8.33 | 201.12% | 119.43x | 155.87x | 7.05x | 14.29x | 1.11x | $39.15M | 1.20% | $220.58M | 1.69 | $3.23B | 71.20 | ||
| ADMA | ADMA BIOLOGICS INC | $9.84 | $8.76 | 12.32% | 13.67x | 11.73x | 4.38x | 5.40x | 0.61x | $116.47M | 5.18% | $408.21M | 1.79 | $2.27B | 9.72 | ||
| HALO | HALOZYME THERAPEUTICS INC | $108.17 | $71.08 | 52.18% | 30.38x | 13.03x | 7.62x | 85.53x | 0.65x | $806.22M | 6.36% | $143.54M | 1.22 | $14.26B | 19.85 | ||
| VCEL | VERICEL CORP | $42.68 | $8.92 | 378.71% | 88.92x | 88.53x | 7.12x | 5.91x | 2.11x | $61.66M | 2.83% | $370.04M | 7.25 | $2.15B | 48.87 | ||
| KRYS | KRYSTAL BIOTECH INC | $346.58 | $86.61 | 300.17% | 41.91x | 45.45x | 23.23x | 7.55x | 2.47x | $257.78M | 2.52% | $1.36B | 46.03 | $9.84B | 42.18 | ||
| RPRX | ROYALTY PHARMA PLC | $61.31 | $38.62 | 58.74% | 32.61x | 11.43x | 10.76x | 3.60x | 0.67x | $2.92B | 10.71% | $9.79B | 21.99 | $43.40B | 36.91 | ||
| TGTX | TG THERAPEUTICS INC | $54.27 | $23.92 | 126.87% | 17.62x | 38.51x | 9.62x | 13.75x | 2.06x | $17.39M | 0.23% | $604.08M | 4.26 | $8.58B | 61.60 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $11.87 | $9.47 | 25.34% | 12.49x | 11.46x | 5.16x | 3.24x | 0.81x | $82.01M | 11.68% | $217.65M | 3.68 | $561.06M | 7.26 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $66.70 | $21.30 | 213.21% | 175.53x | 17.96x | 3.79x | 2.04x | 1.10x | $738.18M | 5.72% | $6.32B | 32.68 | $16.22B | 42.06 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $3.21 | $2.24 | 43.06% | 16.05x | 13.88x | 1.97x | 3.08x | 0.83x | $5.67M | 2.24% | $82.53M | 1.04 | $189.58M | 10.14 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $286.29 | $93.66 | 205.67% | 28.43x | 30.98x | 19.77x | 5.90x | 2.13x | $130.62M | 2.27% | $967.52M | 48.22 | $5.83B | 20.90 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $548.05 | $157.43 | 248.12% | 31.62x | 28.34x | 11.05x | 6.86x | 2.50x | $3.80B | 2.73% | $20.25B | 79.81 | $134.74B | 24.48 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $254.28 | $195.36 | 30.16% | 16.66x | 9.85x | 3.49x | 3.44x | 0.69x | $1.62B | 10.08% | $4.80B | 75.98 | $19.28B | 11.93 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.22 | $6.46 | -81.11% | 8.71x | -4.12x | 1.50x | 1.61x | 0.07x | $19.58M | 27.70% | $44.20M | 0.76 | $22.32M | 2.92 | ||
| TECH | BIO-TECHNE CORP | $72.32 | $15.99 | 352.41% | 101.86x | 34.66x | 9.34x | 5.43x | 1.87x | $269.60M | 2.39% | $2.09B | 13.34 | $11.40B | 44.55 | ||
| MDXG | MIMEDX GROUP INC | $4.33 | $1.11 | 290.12% | 108.25x | -38.59x | 1.80x | 2.92x | 1.53x | $44.50M | 6.95% | $216.00M | 1.46 | $512.51M | 22.47 | ||
| EXEL | EXELIXIS INC | $54.08 | $28.49 | 89.85% | 16.44x | 16.81x | 5.57x | 7.27x | 1.45x | $1.17B | 8.64% | $1.84B | 7.35 | $13.28B | 12.21 | ||
| UTHR | UNITED THERAPEUTICS CORP | $513.12 | $224.02 | 129.05% | 16.97x | 18.75x | 6.93x | 3.44x | 2.29x | $1.09B | 5.00% | $6.40B | 150.24 | $20.20B | 12.05 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $834.04 | $415.76 | 100.61% | 19.89x | 17.86x | 5.52x | 2.71x | 1.31x | $3.76B | 4.39% | $31.71B | 308.48 | $86.12B | 14.98 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $38.15 | $32.86 | 16.08% | 12.15x | 10.05x | 2.30x | 2.22x | 0.72x | $354.90M | 16.06% | $999.24M | 17.25 | $1.83B | 6.52 | ||
| INCY | INCYTE CORP | $127.81 | $60.30 | 111.96% | 15.74x | 16.82x | 4.40x | 4.08x | 2.11x | $1.92B | 7.50% | $6.34B | 31.66 | $21.96B | 10.62 |